AI assistant
Sending…
Coloplast — Director's Dealing 2017
Sep 13, 2017
3358_rpt_2017-09-13_6e92f6e1-741e-41e2-9b40-1169a92084a4.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Nasdaq Copenhagen
13 September 2017
Coloplast A/S Holtedam 1 3050 Humlebæk Denmark Tel: +45 4911 1111 www.coloplast.com CVR-nr. 69749917
Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transactions concern the sale of shares.
| Name | Lars Rasmussen |
|---|---|
| Reason | CEO |
| Issuer | Coloplast A/S |
| ISIN code | DK0060448595 |
| Description | Shares |
| Transaction | Sale of shares |
| Trade date | 11 September 2017 |
| Market | Nasdaq Copenhagen |
| Number | 40,000 |
| Transaction value per share in DKK | 517.22 |
| Transaction value in DKK | 20,688,800 |
| Name | Lars Rasmussen |
|---|---|
| Reason | CEO |
| Issuer | Coloplast A/S |
| ISIN code | DK0060448595 |
| Description | Shares |
| Transaction | Sale of shares |
| Trade date | 12 September 2017 |
| Market | Nasdaq Copenhagen |
| Number | 80,000 |
| Transaction value per share in DKK | 511.41 |
| Transaction value in DKK | 40,912,800 |
Kind regards, Coloplast A/S
Anne-Sofie Søegaard
This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Anne-Sofie Søegaard, tel. +45 4911 1924.
More from Coloplast
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23